Programme | EAHAD 2025
View the programme for an outline of the engaging topics being presented at EAHAD 2025.
View the programme for an outline of the engaging topics being presented at EAHAD 2025.
Nature Reviews Cancer – Understanding the early steps of cancer development is crucial for cancer prevention. In this Review, the authors summarize the advantages and…
SEN Radio has parted ways with prominent cricket journalist Peter Lalor halfway through Australia’s tour of Sri Lanka over his social media activity relating to…
CA: A Cancer Journal for Clinicians is ACS’ flagship clinical oncology journal publishing information about the prevention, early detection, and treatment of cancer.
The Year in Review in Oncology 2024 brought to you by some of the Worlds TOP experts!
In this issue of Blood, Liu et al1 report the results of a phase 1 clinical trial using pegcrisantaspase (PegC) in combination with venetoclax in relapsed
An abstract is unavailable.
Key PointsRuxolitinib therapy was associated with improvements in lung function for participants with BOS.Clinical responses were more commonly observed in
Balstilimab plus botensilimab improved ORR over botensilimab alone in MSS mCRC without liver metastases, per phase 2 data.
UPMC Hillman Cancer Center and the University of Pittsburgh announced that Kathryn Schmitz was appointed interim director of UPMC Hillman. José P. Zevallos was appointed as…